| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/16/2004 | US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 09/16/2004 | US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/16/2004 | US20040180886 Cathepsin S inhibitors |
| 09/16/2004 | US20040180885 Indole derivatives, process for preparation of the same and use thereof |
| 09/16/2004 | US20040180884 Dibenzocycloheptene compound |
| 09/16/2004 | US20040180881 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180871 Anti-inflammatory compositions and methods |
| 09/16/2004 | US20040180052 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 09/16/2004 | US20040180046 Bispecific molecules and uses thereof |
| 09/16/2004 | US20040180040 Methods and compositions for directing cells to target organs |
| 09/16/2004 | US20040180037 Use of IL-7 for treating autoimmune diseases, in particular insulin-dependent diabetes mellitus |
| 09/16/2004 | DE3717389B4 Neue naphthylaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in der Human- und Veterinärmedizin und in der Kosmetik New naphthylaromatische compounds, processes for their preparation and their use in human and veterinary medicine and cosmetics |
| 09/16/2004 | CA2796381A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2518199A1 Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications |
| 09/16/2004 | CA2517974A1 Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |
| 09/16/2004 | CA2512280A1 Benzofuran derivative |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 09/15/2004 | EP1456396A1 Hybrid glycosylated products and their production and use |
| 09/15/2004 | EP1456383A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456347A2 Antibodies that immunospecifically bind to blys |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456221A2 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 09/15/2004 | EP1456219A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 09/15/2004 | EP1456214A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456212A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 09/15/2004 | EP1456210A1 Pyrazolyl-substituted triazoloquinoxalines |
| 09/15/2004 | EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 09/15/2004 | EP1456205A1 Imidazoquinoline derivatives |
| 09/15/2004 | EP1456204A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 09/15/2004 | EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 09/15/2004 | EP1456200A1 Lactams as tachykinin antagonists |
| 09/15/2004 | EP1456197A1 Piperidine-2,6-diones that are heterocyclically substituted in position 3 |
| 09/15/2004 | EP1456188A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 09/15/2004 | EP1456163A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456160A2 Vitamin d analogues |
| 09/15/2004 | EP1455900A1 Methods of treating bacterial infections in dogs and cats |
| 09/15/2004 | EP1455841A2 Osteopontin-related compositions and methods |
| 09/15/2004 | EP1455818A2 Applications of spores |
| 09/15/2004 | EP1455817A2 Staphylococcus aureus exopolysaccharide and process |
| 09/15/2004 | EP1455813A2 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung disease |
| 09/15/2004 | EP1455812A2 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment |
| 09/15/2004 | EP1455810A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 09/15/2004 | EP1455792A1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 09/15/2004 | EP1455791A1 Method for administering birb 796 bs |
| 09/15/2004 | EP1455783A1 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist |
| 09/15/2004 | EP1455775A2 Methods and compositions for modulating the immune system and uses thereof |
| 09/15/2004 | EP1455766A2 Thymosin alpha 1 peptide/polymer conjugates |
| 09/15/2004 | EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| 09/15/2004 | EP1455759A2 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 09/15/2004 | EP1455753A1 Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant |
| 09/15/2004 | EP1455734A1 Compositions comprising phenyl-glycine derivatives |
| 09/15/2004 | EP1455700A2 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 09/15/2004 | EP1455593A2 Methods and compositions for promoting growth and innate immunity in young animals |
| 09/15/2004 | EP1363902B1 Chemical compounds |
| 09/15/2004 | EP1339420B1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 09/15/2004 | EP1244442B1 Method for detecting nucleotide synthesis inhibitors having fewer side effects |
| 09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/15/2004 | EP1173440B1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 09/15/2004 | EP1140077B1 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 09/15/2004 | EP1133487B1 Antioxidants |
| 09/15/2004 | EP1056359B1 Product and method to reduce stress induced immune suppression |
| 09/15/2004 | EP1023319B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 09/15/2004 | EP1001806B1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 09/15/2004 | EP0998290B1 Use of vitamin d compounds to prevent transplant rejection |
| 09/15/2004 | EP0988046B1 Oil-free pharmaceutical compositions containing cyclosporin a |
| 09/15/2004 | EP0941082B1 New use for 1,3-propanediol derivatives |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0859601B1 Prolonged release of gm-csf |
| 09/15/2004 | EP0841939B1 Therapeutic agents and autoimmune diseases |
| 09/15/2004 | EP0837881B1 CONJUGATES OF alpha-MSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 09/15/2004 | EP0737068B1 2,3-diaryl-1-benzopyrans for treating dermatitis |
| 09/15/2004 | EP0714404B1 Anti-inflammatory peptides |
| 09/15/2004 | CN1529714A Modified interfron alpha with reduced immunogenicity |
| 09/15/2004 | CN1529701A Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |
| 09/15/2004 | CN1529699A Novel sulfonic acid derivatives |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529618A Induction of tolerance |
| 09/15/2004 | CN1529617A Method for treaing autoimmune diseases in subject and in vitro diagnostic assays |
| 09/15/2004 | CN1529615A Method and composition for oral vaccination |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529607A Treatment of T cell disorders |
| 09/15/2004 | CN1529602A Use of N-phenyl-2-pyrimidneasmine derivative against mast cell-based diseases like allergic disorders |
| 09/15/2004 | CN1529590A Compositions and methods to treat neovascularization and disease associated with thereof |
| 09/15/2004 | CN1528882A Amauoderma rude liquid fermenting method and product obtained thereby |
| 09/15/2004 | CN1528792A Method for extracting red blood cell membrane extract and its use |
| 09/15/2004 | CN1528783A Bursopoietin extracting method and its use in disease treating and immune |
| 09/15/2004 | CN1528747A Immunoregulator for inhibiting interleukin-4, stimulus g interferon and preparing method thereof |
| 09/15/2004 | CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate |
| 09/15/2004 | CN1528335A Shii-take fungus polysaccharide drop pill and preparing method thereof |
| 09/15/2004 | CN1528303A Loratadine drop pill and preparing method thereof |
| 09/15/2004 | CN1166678C Purine derivatives |
| 09/15/2004 | CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents |
| 09/15/2004 | CN1166643C 4-phenyl-pyrimidine derivatives |
| 09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |